middle.news
Pathkey.AI’s TrialKey AI Predicts Clinical Trial Success with 73% Accuracy
8:42am on Monday 8th of September, 2025 AEST
•
Healthcare
Read Story
Pathkey.AI’s TrialKey AI Predicts Clinical Trial Success with 73% Accuracy
8:42am on Monday 8th of September, 2025 AEST
Key Points
TrialKey aligned with 8 of 11 clinical trial outcomes (73%)
Average hypothetical share price gain of +76% during observation windows
Notable share price surge, Abivax up ~785% post positive Phase 3 results
TrialKey analyzes over 500,000 trials with 1,500+ variables to estimate Probability of Success
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Pathkey.Ai (ASX:PKY)
OPEN ARTICLE